 |
1 Disease |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- ||| AMG 581 / Amgen
Trial completion: MAD: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective (clinicaltrials.gov) - Mar 7, 2016
P1, N=52, Completed, Sponsor: Amgen
Active, not recruiting --> Completed
- || AMG 581 / Amgen
Enrollment closed: MAD: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective (clinicaltrials.gov) - Feb 9, 2016
P1, N=52, Active, not recruiting, Sponsor: Amgen
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- ||| AMG 581 / Amgen
Trial completion: FIH: Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 (clinicaltrials.gov) - Nov 1, 2015
P1, N=70, Completed, Sponsor: Amgen
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||| AMG 581 / Amgen
New P1 trial: FIH: Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581 (clinicaltrials.gov) - Oct 5, 2015
P1, N=70, Active, not recruiting, Sponsor: Amgen
- ||| AMG 581 / Amgen
Enrollment open: MAD: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective (clinicaltrials.gov) - Oct 2, 2015
P1, N=52, Recruiting, Sponsor: Amgen
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| AMG 581 / Amgen
New P1 trial: MAD: Multiple Ascending Dose Study on Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects or Subjects With Schizophrenia or Schizoaffective (clinicaltrials.gov) - Jul 22, 2015
P1, N=52, Not yet recruiting, Sponsor: Amgen